Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock

Circulation

Volumn 99, Issue 2, 1999, Pages 271-275

  Avontuur, Jurgen A M ^a   Boomsma, Frans ^b   Van Den Meiracker, Anton H ^b   De Jong, Frank H ^b   Bruining, Hajo A ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Endothelin; Endothelium derived factors; Shock

Indexed keywords

ENDOTHELIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPTIC SHOCK; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0032926506     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.2.271     Document Type: Article

References (45)

1. Lüscher TF, Boulanger CM, Yang Z, Noll G, Dohi Y. Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation. 1993;87(suppl V):V36-V44.
2. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
3. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet. 1994;344:852-854.
4. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
5. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
6. Boulanger C, Lüscher TF. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest. 1990;85: 587-590.
7. Lerman A, Sandok EK, Hildebrand FL Jr, Burnett JC Jr. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circulation. 1992;85:1894-1898.
8. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Löffler BM, Müller M, Neidhart W, Ramuz H. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993;365:759-761.
9. Richard V, Hogie M, Clozel M, Löffler B, Thuillez C. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation. 1995;91:771-775.
10. Filep JG. Endogenous endothelin modulates blood pressure, plasma volume, and albumin escape after systemic nitric oxide blockade. Hypertension. 1997;30:22-28.
11. Thomson LL, Iversen HK, Emmeluth C, Bie P. Venous plasma levels of endothelin-1 are not altered immediately after nitroglycerin infusion in healthy subjects. Eur J Clin Pharmacol. 1995;48:139-142.
12. Ahlborg G, Lundberg JM. Nitric oxide-endothelin-1 interaction in humans. J Appl Physiol. 1997;82:1593-1600.
13. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med. 1993;328:953-963.
14. Avontuur JA, Bruining HA, Ince C. Nitric oxide causes dysfunction of coronary autoregulation in endotoxemic rats. Cardiovasc Res. 1997;35: 368-376.
15. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg. 1991;214:621-626.
16. Rees DD, Palmer RM, Schulz R, Hudson HF, Moncada S. Characterisation of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990;101:746-752.
17. Meyer J, Traber LD, Nelson S, Nelson S, Lentz CW, Nakazawa H, Herndon DN, Noda H, Traber DL. Reversal of hyperdynamic responses to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol. 1992;73:324-328.
18. Petros A, Lamb G, Leone A, Moncada S, Bennet D, Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res. 1994;28:34-39.
19. Kiehl MG, Ostermann H, Meyer J, Kienast J. Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock. Intensive Care Med. 1997;23:561-566.
20. Avontuur JAM, Tutein Nolthenius RP, van Bodegom JW, Bruining HA. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study. Crit Care Med. 1998;26:660-667.
21. Weitzberg E, Lundberg JM, Rudehill A. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock. 1991;33:222-227.
22. Sanai L, Haynes WG, MacKenzie A, Grant IS, Webb DJ. Endothelin production in sepsis and the adult respiratory distress syndrome. Intensive Care Med. 1996;22:52-56.
23. Bone RC, Fischer CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. Sepsis syndrome: a valid clinical entity. Crit Care Med. 1989;17: 389-393.
24. Smits P, Hofman H, Rosmalen F, Wollersheim T, Thien T. Endothelin-1 in patients with Raynaud's phenomenon. Lancet. 1991;337:236.
25. Phizackerley PJ, Al-Dabbagh SA. The estimation of nitrate and nitrite in saliva and urine. Anal Biochem. 1983;131:242-245.
26. Huizenga NA, Koper JW, de Lange P, Pols HA, Stolk RP, Grobbee DE, de Jong FH, Lamberts SW. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. J Clin Endocrinol Metab. 1998;83:47-54.
27. Ohta K, Hirata Y, Imai T, Kanno K, Emori T, Shiehiri M, Marumo F. Cytokine-induced release of endothelin-1 from porcine renal epithelial cell line. Biochem Biophys Res Commun. 1990;169:578-584.
28. Kahaleh MB, Fan PS. Effect of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol. 1997;15:163-167.
29. Anggard E, Gallon S, Rae G, Thomas R, McLoughin L, de Nucci G, Vane JR. The fate of radioiodinated endothelin-1 and endothelin-3 in the rat. J Cardiovasc Pharmacol. 1989;13(suppl 5):S46-S49.
30. Koyama H, Tabata T, Nishzawa Y, Inoue T, Morii H, Yamaji T. Plasma endothelin levels in patients with uraemia. Lancet. 1989;333:991-992.
31. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, Oz MC, Oliver JA. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122-1125.
32. Vierhapper H, Wagner O, Nowotny P, Waldhäusl W. Effect of endothelin-1 in man. Circulation. 1990;81:1415-1418.
33. Kaasjager KAH, Koomans HA, Rabelink TJ. Endothelin-1-induced vasopressor responses in essential hypertension. Hypertension. 1997;30: 15-21.
34. Haynes WG, Ferro CJ, O'Kane KPJ, Somerville D, Lomax CC, Webb DJ. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation. 1996;93: 1860-1870.
35. Kiowski W, Sutsch G, Hunziker P, Muller P, Kim J, Oechslin E, Schmitt R, Jones R, Bertel O. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet. 1995;346:732-736.
36. A endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats. Circulation. 1997;95:240-244.
37. Saijonmaa O, Risimäki A, Fyhrquist F. Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem Biophys Res Commun. 1990;173:514-520.
38. Harrison VJ, Barnes K, Turner AJ, Wood E, Corder R, Vane JR. Identification of endothelin-1 and big endothelin-1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc Natl Acad Sci U S A. 1995;92:6344-6348.
39. Teerlink JR, Carteaux JP, Löffler BM, Clozel M, Clozel JP. Big endothelin as a probe for the endothelin paracrine system: dissociation of plasma endothelin levels and hemodynamic effects. Circulation. 1993; 88(suppl I):1-182. Abstract.
40. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem. 1992;267:16066-16068.
41. Leaf CD, Wishnok JS, Hurley JP, Rosenblad D, Fox JG, Tannenbaum SR. Nitrate biosynthesis in rats, ferrets and humans: precursor studies with L-arginine. Carcinogenesis. 1990;11:855-858.
42. Lamberts SW, Bruining HA, de Jong FH. Corticosteroid therapy in severe illness. N Engl J Med. 1997;337:1285-1292.
43. Kalsner S. Mechanism of hydrocortisone potentiation of responses to epinephrine and norepinephrine in rabbit aorta. Circ Res. 1969;24: 383-395.
44. G-nitro-L-arginine and comparisons to alcohol. Life Sci. 1991;50:35-40.
45. Giordano M, Vermeulen M, Trevani AS, Dran G, Andonegui G, Geffner JR. Nitric oxide synthase inhibitors enhance plasma levels of corticosterone and ACTH. Acta Physiol Scand. 1996;157:259-264.